Neo Ivy Capital Management’s Alkermes ALKS Stock Holding History

Neo Ivy Capital Management’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-29,756	Closed	-$893K	–	342
2025 Q3	$893K	Buy	29,756 +13,606	+84%	+$384K	0.22%	155
2025 Q2	$462K	Buy	+16,150	New	+$481K	0.15%	196
2023 Q4	–	Sell	-20,132	Closed	-$564K	–	285
2023 Q3	$564K	Buy	+20,132	New	+$590K	0.25%	141
2022 Q4	$97K	Buy	+3,702	New	+$88.6K	0.07%	261
2022 Q3	–	Sell	-908	Closed	-$27K	–	375
2022 Q2	$27K	Buy	+908	New	+$26.1K	0.07%	287
2022 Q1	–	Sell	-259	Closed	-$6K	–	475
2021 Q4	$6K	Buy	+259	New	+$6.81K	0.01%	396
2021 Q2	–	Sell	-1,574	Closed	-$29K	–	435
2021 Q1	$29K	Buy	1,574 +132	+9%	+$2.7K	0.03%	374
2020 Q4	$29K	Buy	+1,442	New	+$26.4K	0.03%	344

Other funds holding ALKS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neo Ivy Capital Management's ALKS Position: Q4 2025 in Review

Neo Ivy Capital Management sold out of Alkermes (ALKS) in Q4 2025, closing a stake of 29,756 shares — an estimated $893K sold.

Neo Ivy Capital Management first reported a position in ALKS in Q4 2020 and held it in 8 quarters. The position peaked at $893K in Q3 2025. 366 funds tracked by Wall St. Rank hold ALKS as of Q4 2025.

Neo Ivy Capital Management reported no remaining Alkermes position as of Q4 2025 after selling out during the quarter.
Neo Ivy Capital Management sold 29,756 Alkermes shares in Q4 2025, an estimated $893K.
Neo Ivy Capital Management first reported a position in Alkermes in Q4 2020 and held it in 8 quarters.
Neo Ivy Capital Management's Alkermes position peaked at $893K in Q3 2025.
366 funds tracked by Wall St. Rank held Alkermes as of Q4 2025.

Based on Neo Ivy Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.